Overview

Effect of Omalizumab (Xolair) on Basophils in Patients With Chronic Idiopathic Urticaria

Status:
Completed
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
This study looks at changes in cell proteins in people with chronic hives treated with omalizumab.
Phase:
Phase 4
Details
Lead Sponsor:
University of Colorado, Denver
Collaborator:
Genentech, Inc.
Treatments:
Omalizumab